This is a Study to Determine the Antidepressant Effects of AZD6765

Completed · Phase 2 · Has a placebo group

Conditions studied: Treatment Resistant Major Depressive Disorder

In brief

The purpose of this study is to determine the antidepressant effects of AZD6765 compared to placebo.

Key facts

Study ID

NCT00986479

Run by

AstraZeneca

People needed

22

Starts

2009-12-01

Expected to finish

2011-12-01

Last updated by the study team

2014-10-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a diagnosis of Major Depressive Disorder, currently depressed without psychotic features
• Females must be of non-childbearing potential.

You may not qualify if…

• Treatment with Clozapine or ECT within 3 months prior to study
• Current or past history of psychotic features or a diagnosis of schizophrenia or any other psychotic disorder as defined in the DSM-IV

Where it is running

• Research Site — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.